Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique.

Transactions of the Royal Society of Tropical Medicine and Hygiene - 1 Jun 2009

Maldonado F, Biot M, Roman F, Masquelier C, Anapenge M, Bastos R, Chuquela H C, Arendt V, Schmit J C, Zachariah R

Abstract excerpt

This study was conducted among individuals taking first-line antiretroviral treatment (ART) for at least 12 months under programme conditions in Maputo, Mozambique in order to report on the level of detectable viraemia and the proportion and types of drug resistance mutations among those with detectable viral loads. HIV-1 RNA viral load levels (lower detection limit <50 copies/ml) were measured, and resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Medication Adherence

Share to Mozambique

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 18804251
DOI: 10.1016/j.trstmh.2008.07.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique.PMID 18804251Read ↗

Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique.Semantic proximity Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

Determinants of virological failure and antiretroviral drug resistance in Mozambique.Semantic proximity Read ↗

Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique.Semantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in MozambiqueSemantic proximity Read ↗

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.Semantic proximity Read ↗

HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique.Semantic proximity Read ↗

Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.Semantic proximity Read ↗

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, ZambiaSemantic proximity Read ↗

Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.